Showing results (1-10 of 19) with videos related to
Sort By:
Pageof 2
Drug Discovery Today. Technologies|July 2, 2014
Enhancing exposure of protein therapeuticsJohn M Beals, Armen B ShanafeltAnalytical Chemistry|March 1, 2005
In vivo deamidation characterization of monoclonal antibody by LC/MS/MSLihua Huang, Jirong Lu, Victor J Wroblewski, et al.Endocrine Reviews|May 13, 2020
The Evolution of Insulin and How it Informs Therapy and Treatment ChoicesIrl B Hirsch, Rattan Juneja, John M Beals, et al.The FEBS Journal|November 26, 2021
Comprehensive insulin receptor phosphorylation dynamics profiled by mass spectrometryZhongping Liao, Chen Zhang, Liyun Ding, et al.Biochemistry|December 5, 2002
Glycosylation of erythropoietin affects receptor binding kinetics: role of electrostatic interactionsRyan J Darling, Uma Kuchibhotla, Wolfgang Glaesner, et al.Endocrine Reviews|January 15, 2024
The Basis for Weekly Insulin Therapy: Evolving Evidence With Insulin Icodec and Insulin Efsitora AlfaJulio Rosenstock, Rattan Juneja, John M Beals, et al.Journal of Diabetes|September 29, 2018
Concentrated insulins: History and critical reappraisalLutz Heinemann, John M Beals, James Malone, et al.Diabetes, Obesity & Metabolism|December 21, 2022
Pharmacokinetic and pharmacodynamic properties of the novel basal insulin Fc (insulin efsitora alfa), an insulin fusion protein in development for once-weekly dosing for the treatment of patients with diabetesTim Heise, Jenny Chien, John M Beals, et al.Biochemistry|August 17, 2005
IL-1beta epitope mapping using site-directed mutagenesis and hydrogen-deuterium exchange mass spectrometry analysisJirong Lu, Derrick R Witcher, Melissa A White, et al.Diabetes|October 4, 2013
Novel PEGylated basal insulin LY2605541 has a preferential hepatic effect on glucose metabolismMary Courtney Moore, Marta S Smith, Vikram P Sinha, et al.Pageof 2